Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport and Hypertension int he Metabolic Syndrome
Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport and Hypertension int he Metabolic Syndrome
批准号:
10472324
负责人:
Jonathan Nizar
金额:
$6.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-01-31
关键词:
AcuteAddressAffectAmericanAnimalsApicalAreaBasic ScienceBioinformaticsBloodBlood PressureBlood VolumeCellsChronicDataDiabetes MellitusDietDiseaseDoseEnvironmentEpithelial CellsEssential HypertensionExcretory functionFacultyFeedbackFinancial costFutureGenesGlucoseHealthHealth Care CostsHormonesHyperinsulinismHypertensionImpairmentIndividualInfusion proceduresInsulinInsulin ReceptorInsulin ResistanceKidneyKnockout MiceKnowledgeLearning SkillMeasuresMedicalMentorsMetabolic syndromeModelingMolecular BiologyMusNatriuresisNephrologyObesityOperative Surgical ProceduresPathogenesisPatientsPatternPhasePhysiciansPhysiologyPlayReceptor ActivationReceptor SignalingRecording of previous eventsRegulationRenal tubule structureResearchRiskRoleScientistSodiumSurfaceSystemTechniquesTestingTissuesTrainingTubular formationUnited StatesWild Type MouseWorkZucker Ratscareerinsulin signalinginterestkidney dysfunctionmouse modelnovelpressurereceptor expressionresponsesalt sensitivesequencing platformsocietal coststooltraffickingtranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
Hypertension in patients with Metabolic Syndrome incurs a large financial, societal, and health cost in the
United States. Despite several lines of evidence that hypertension in the Metabolic Syndrome has a distinct
cause from idiopathic (essential) hypertension, this cause is not known and patients are treated empirically.
Contributions from many labs over the last 30 years have supported the hypothesis that enhanced insulin
signaling in the kidney plays a critical role in the pathogenesis of this disease. The Applicant's preliminary data
confirms the hypothesis that insulin action in the kidney contributes to hypertension in a mouse model of
Metabolic Syndrome and suggests that proximal tubular sodium transport may be increased, expanding blood
volume, and increasing blood pressure. The Applicant has (1) characterized: a mouse model to study the
intersection of the kidney, blood pressure, and Metabolic Syndrome and (2) generated a novel inducible tubule
insulin receptor knockout mouse to study the contribution of insulin receptor signaling to sodium transport and
blood pressure. In addition to the Applicant's contributions, the mentoring and scientific environment make him
an ideal candidate to develop independence in renal physiology research addressing this important question.
Here, the Applicant proposes three aims to study the contribution of insulin receptor signaling in the Metabolic
Syndrome to acute pressure natriuresis (Aim 1), to regulators of proximal tubule sodium transporter activity in
response to acute and chronic hypertension (Aim 2), and to patterns within the proximal tubule epithelial cell
transcriptome generated by insulin receptor signaling, the Metabolic Syndrome, or both (Aim 3). Successful
completion of these aims will begin to bridge the gap in knowledge between the role of insulin in whole animal
physiology and transporter activity and regulation in individual cells. In addition, through this training
mechanism the Applicant will learn the skills to successfully conduct independent research in basic science
nephrology.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport and Hypertension int he Metabolic Syndrome
-
批准号:10001474
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2019
-
负责人:Jonathan Nizar
-
依托单位:
Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport and Hypertension int he Metabolic Syndrome
-
批准号:9769056
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2019
-
负责人:Jonathan Nizar
-
依托单位:
Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport and Hypertension int he Metabolic Syndrome
-
批准号:10240479
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2019
-
负责人:Jonathan Nizar
-
依托单位:
海外基金